Gyre Therapeutics, Inc. (GYRE) Total assets 2017–2025
Gyre Therapeutics, Inc. (GYRE) total assets at each fiscal year-end, per SEC filings.
$219.8MFY2025 · since FY2017: $39.5M → $219.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $219.8M | +75.2% |
| FY2024 | $125.4M | +7.6% |
| FY2023 | $116.5M | +37.5% |
| FY2022 | $84.8M | +52.3% |
| FY2021 | $55.7M | -41.3% |
| FY2020 | $94.8M | — |
| FY2018 | $124.9M | +216.1% |
| FY2017 | $39.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GYRE financial trends
GYRE RevenueGYRE Net incomeGYRE Net marginGYRE Gross profitGYRE Gross marginGYRE Operating incomeGYRE Operating marginGYRE Operating cash flowGYRE Free cash flowGYRE Capital expendituresGYRE Return on equityGYRE Stock buybacksGYRE Dividends paidGYRE Total liabilitiesGYRE Shareholders’ equityGYRE overview →